The proposed OPPS rule would increase payment rates by 1.75 percent while paying hospitals 22.5 percent less than the average sales price for drugs purchased through the 340B Drug Pricing Program. CMS did not mention Meaningful Use Stage 3 reporting requirements, which are slated to begin Jan. 1, 2018.
Tom Nickels, executive vice president for the AHA, expressed concern CMS did not “propose relief” from the reporting requirements established under Meaningful Use Stage 3, which he called unrealistic and unattainable.
“The mandate for all hospitals and critical access hospitals to switch to new EHR functionality and report for a full year is unattainable and is at odds with the meaningful use flexibility proposed for eligible clinicians in the Quality Payment Program proposed rule,” Mr. Nickels wrote.
More articles on health IT:
DOD initiates 2nd Cerner EHR go-live
Survey: Do organizations plan to implement more security after WannaCry, Petya?
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
